Chagas disease. Serologic response to crude and semipurified T. cruzi antigens in different clinical groups of patients;Enfermedad de chagas. Reactividad serologica hacia antigenos crudos y semipurificados del T. cruzi en distintos grupos clinicos de pacientes

Medicina

Volumn 57, Issue 2, 1997, Pages 161-168

  Cervetta, Liliana ^a,b,c   Basso, Beatriz ^a   Castro, Irma ^a   Santamarina, Norberto ^a   Moretti, Edgardo ^a  

^a Servicio Nacional de Chagas   (Argentina)

^b CONICOR ^*  (Argentina)

^c NONE   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

PARASITE ANTIGEN;

ADOLESCENT; ADULT; ANIMAL; ARTICLE; BLOOD; CHAGAS DISEASE; CHILD; HUMAN; IMMUNOLOGY; INFANT; MIDDLE AGED; PRESCHOOL CHILD; TRYPANOSOMA CRUZI;

ADOLESCENT; ADULT; ANIMALS; ANTIGENS, PROTOZOAN; CHAGAS DISEASE; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; MIDDLE AGED; TRYPANOSOMA CRUZI;

EID: 0031302063     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Beltz L, Sztein M, Kierzenbaum F. Novel mechanism for T. cruzi induced suppression of human lymphocytes. J Immunol 1988: 141:289-94.
2. Cunningham D, Khun E, Rowland C. Suppression of humoral responses during T. cruzi infection in mice. Infect Immun. 1978; 22: 155-60.
3. Harel-Bellan A, Joskowicz E, Fradelizi D, Elsen H. Modification of T cell proliferation and IL-2 production in mice infected with T. cruzi. Proc Natl Acad Sci 1983: 80: 3466-9.
4. Kierszenbaum F. On evasion of T. cruzi from the host immune lymphoproliferative responses to trypanosomal antigens during acute and chronic experimental Chagas' disease. Immunology 1981; 44: 641-8.
5. Kierszenbaum F, Moretti E, Sztein M. Molecular basis of T cruzi induced immunosuprression. Altered expression by activated human lymphocytes of molecules with regulate antigen recognition and progression through the cell cycle. Biol Res 1993; 26: 197-207.
6. Liew F, Scott M, Liu D, Croft L. Suppressive substance produced by T cell from mice chronically infected with T. cruzi. I. Preferential inhibition of delayed type hypersensitivity. J Immunol 1987; 139: 2452-7.
7. Texeira A, Texeira G, Macedo V, Prata A. Acquired cell-mediated immunodepression in acute Chagas'disease, J Clin Invest 1978; 62: 1132-41.
8. Voltarelli J, Donadio E, Falcao R. Immunosupression in human acute Chagas disease. Trans Roy Soc Trop Med Hyg 1987; 81: 169-70.
9. Gruppi A, Gea S, Moretti E, Vottero-Cima E. Human antibodies against T. cruzi exoantigens recognizing parasite surface antigens and heart tissue components. Int Arch Allergy Appl Immunol 1987; 90: 119-23.
10. Hudson L. Autoimmune phenomena in chronic chagasic cardiopathy. Parasitol Today 1985; 1: 6-9.
11. Snacy D, Flint JE. Wood JN, et al. A monoclonal antibody with specificity for T cruzi central and peripheral neurones and glia. Clin Exp Immunol 1983; 54: 617-24.
12. Szarfman A, Terranova VP, Rennard SI, et al. Antibodies to laminin in Chagas' disease. J Exp Med. 1982; 155: 1161-9.
13. Andrade S, Stocker S, Pimentel S, Grimaud A. Reversibility of cardiac fibrosis in mice chronically infected with T. cruzi, under specific chemotherapy. Mem Inst Oswaldo Cruz 1991, 86: 187-200.
14. Ben Jounes-Chennoufi A, Honteberye-Joskowicz M, Tricottet U, Eisen H, Reynes M, Said G. Persistence of T cruzi antigens in the inflammatory lesions of chronically infected mice. Trans Roy Soc Trop Med Hyg 1988; 82: 77-83.
15. Jones E, Coley D, Tostes S, Lopes E, Unencak C, McCurley L. Amplification of a T cruzi DNA sequence from inflammatory lesions in human chagasic cardiomyopathy. Am J Trop Med Hyg. 1993; 48: 348-57.
16. Andrade Z. Pathogenesis of Chagas'disease Res Immunol 1991; 142: 126-9.
17. Minoprio P, Coutinho A, Spinella S, Hontebeyre J. Xid immunodeficiency imparts increased parasite clearance and resistance to pathology in experimental Chagas' disease, Inf Immunol 1991; 3: 427-33.
18. Tarleton R, Koller B, Latour A, Postan M. Susceptibility of beta-2-microglobulin-deficient mice to T. cruzi infection. Nature 1992; 356: 338-40.
19. Cossio PM , Bustuoabad O, Paterno E, et al. Experimental myocarditis induced in Swiss mice by homologous heart immunization resembles chronic experimental Chagas' disease. Clin Exp Immunol 1984; 33: 165-75.
20. Wood J, Hudson L, Jessell M, Yamamoto M. A monoclonal antibody defining antigenic determinant on subpopulations of mammalian neurones and T cruzi parasites. Nature 1982; 296: 34-8.
21. Barcklay C, Cerisola J, Lugones H, Ledesma O, Lopez Silva J, Moura G. Aspectos farmacológicos y resultados terapéuticos del Benznidazol en el tratamiento de la infección chagásica. Prensa Med Argent 1978; 65: 239-44.
22. Bocca Tourres C. La Enfermedad de Chagas en el periodo agudo y su tratamiento con BAY 2502. Bol Chil Parasitol 1969; 24: 24-7.
23. Cerisola J, Fatala Chaben N, Lazzari J. Evolución serológica de pacientes con Enfermedad de Chagas aguda tratados con BAY 2502. Bol Chil Parasitol. 1969; 24: 54-9.
24. Cerisola J, Fatala Chaben N, Lazzari J, Lugones H, Ravinovich L. Tratamiento de la Enfermedad de Chagas. 1972. 6° Premio Cientifico E. Antonio Rizzuto.
25. Moya P. Paolasso R, Blanco S, et al. Tratamiento de la Enfermedad de Chagas con Nifurtimox durante los primeros meses de vida, Medicina (Buenos Aires) 1985; 45: 553-8.
26. Cervetta L, Basso B, Moretti E, Castro I, Santamarina N. Estudio del perfil inmunológico en la Enfermedad de Chagas crónica. Presencia Bioquimica. 1993; 144: 9-15.
27. Avila Reis D, Gazzinelli R, Gazzinelli G, Colley D. Antibodies to T. cruzi express idiotypic patterns that can differentiate between patients with asymptomatic or severe Chagas' disease. J Immunol 1993; 150: 1611-8.
28. Gea S, Rodriguez P, Vottero-Cima E. Characterization of T cruzi antigens recognized by sera from patients with chronic Chagas' disease. Int Arch Allergy Appl Immunol 1987; 84: 410-13.
29. Levin M. et al. Identification of major T. cruzi antigenic determinant in chronic Chagas' heart disease. Am J Trop Med Hyg 1989; 41: 530-8.
30. Sadigursky M. et al. Association of elevated antisarcolema and antiidiotype antibodies levels with the clinical and pathologic expression of chronic Chagas' myocarditis. Circulation 1989; 80: 1269-76.
31. Ternynck T, Bleur C, Gregoire J, et al. Comparison between autoantibodies arising during T. cruzi infection in mice and natural autoantibodies. J Immunol 1990; 14: 1504-11.
32. Kuschnir E, Vives J, Sgammini H, Kinkelstein C, Rivas J, Santamarina N. Valoración de la reserva cardíaca en pacientes chagāsicos. Rev Fed Arg Cardiol 1979; 8: 8-35.
33. Basso B, Moretti E, Dominguez M. Cultivo de Tcruzi en medio monofásico con aireación para la obtención de antigenos. Medicina (Buenos Aires) 1980; 4: 428-32.
34. Fruit J, Afchain D, Petitprez A, Capron A. T cruzi location of specific antigen of the surface of bloodstream trypomastigote and culture forms. Expt Parasitol 1978; 45: 183-9.
35. Boyden S The absorption of protein on the erythrocytes treated with tannic acid and subsequent hemagglutination by antiprotein sera. J Exper Med 1951, 93: 107-11.
36. Sluyterman L, Wijdenes J. Chromatofocusing: Isoelectricfocusing on ion exchanger. I. General principles. J Chomatogr 1978; 150: 17-30.
37. Siuyterman L, Wijdenes J. Chromatofocusing: Isoelectricfocusing on ion exchanger. II. Experimental verification. J Chromatogr 1978; 150: 31-5.
38. Lowry O, Rosebrough N, Farr A, Randall R. Protein measurement with the Folin Fenol reagent. J Biol Chem 1951; 193: 265-75.
39. Woo P. The haematocrit centrifuge for the detection of trypanosomoasis in blood. Can J Zool 1969; 47: 921-4.
40. Neal R, Miles R. Indirect hemagglutination test for Chagas' disease with a simple method for survey work. Rev Med Trop. Sao Paulo 1970; 12: 325-8.